BLOODOMICS LTD

Company number 14720234 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

BLOODOMICS LTD - Analysis Report

Company Number: 14720234

Analysis Date: 2025-07-29 17:16 UTC

  1. Risk Rating: LOW
    The company is newly incorporated (March 2023) with a micro-entity reporting status, showing positive net current assets and no overdue filings. The modest current assets relative to current liabilities provide a comfortable short-term liquidity position. No indications of distress or regulatory non-compliance are evident.

  2. Key Concerns:

  • Limited operational history: The company has less than two years of financial data, which limits trend analysis and assessment of business sustainability.
  • Concentration of control: One individual (Dr. Nicholas Stephen Gleadall) holds 75-100% ownership and voting rights, which may present governance and succession risks.
  • Small scale and resources: Being a micro-entity with only three employees may constrain growth potential and operational resilience.
  1. Positive Indicators:
  • Strong liquidity position with net current assets of £39,219 against current liabilities of £9,830.
  • Compliance with filing requirements: No overdue accounts or confirmation statements, indicating good regulatory discipline.
  • Presence of directors with relevant professional backgrounds (computer programming and medicine) aligned with the IT consultancy SIC code.
  1. Due Diligence Notes:
  • Verify the nature and sustainability of revenue streams and business model given the early stage and limited financial history.
  • Review any contractual obligations or contingent liabilities not reflected in the balance sheet.
  • Assess the corporate governance framework given the ownership concentration and whether any minority interests or external investors exist.

Perspective: Investment Risk Assessor · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.